• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, October 20, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

New York City virus database may advance research into factors contributing to respiratory illness severity

Bioengineer by Bioengineer
January 18, 2024
in Health
Reading Time: 3 mins read
0
New York City virus database may advance research into factors contributing to respiratory illness severity
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Viral respiratory infections are a significant public health concern. A study publishing January 18th in the open access journal PLOS Biology by Marta Galanti at Columbia University, New York, United States and colleagues used longitudinal cohort data to create an interactive, publicly-available website, The Virome of Manhattan Project: Virome Data Explorer to visualize cohort characteristics, infection events, and illness severity factors.

New York City virus database may advance research into factors contributing to respiratory illness severity

Credit: National Cancer Institute, Unsplash (CC0, https://creativecommons.org/publicdomain/zero/1.0/)

Viral respiratory infections are a significant public health concern. A study publishing January 18th in the open access journal PLOS Biology by Marta Galanti at Columbia University, New York, United States and colleagues used longitudinal cohort data to create an interactive, publicly-available website, The Virome of Manhattan Project: Virome Data Explorer to visualize cohort characteristics, infection events, and illness severity factors.

Viral respiratory infections may lead to severe outcomes. However, better understanding of host response, host genetic makeup, and bacterial coinfections is required to develop effective therapeutics. In order to contribute to epidemiological research on factors contributing to disease severity, the researchers conducted a longitudinal cohort study, surveilling respiratory viruses for 19 months between 2016-2018 in New York City. They analyzed over 800 nasopharyngeal samples with clinical data, including self-reported symptoms from 214 participants. From these data, researchers created the Virome Data Explorer, a publicly-available database. Users can access cohort data to visualize and analyze changes and patterns in infections, symptoms, and illness outcomes.

While the database shares important cohort data related to infections, symptoms, and gene activity, the project has several limitations. Adults over the age of 65 were excluded from the cohort, even though according to the authors, respiratory viruses may lead to “extremely serious complications, particularly in infants, elders, and immunocompromised hosts”. Ages of children under 10 were not stratified, obscuring symptom and illness information specific to infants, another high-risk demographic. Vaccination status, immunocompromised conditions, and medicine uptake during infection course were also not among the data collected from study participants, which may limit the applications of the Virome Data Explorer.

According to the authors, “We present a cohort study, consisting of hundreds of samples, that depicts the transcriptional changes driven by respiratory viral infection. We have compiled these data to build a publicly-available, user-friendly web-based resource where any user can compare, longitudinally over the course of 19 months, patterns of viral positivity, symptomatology and transcriptomic changes for the individuals enrolled.”

The authors add, “This is a resource paper aiming at characterizing the host response to common and often asymptomatic viral respiratory infections. We collected and made available a 2-year longitudinal dataset including molecular data and symptoms records for over 100 participants from different age groups in NYC.”

#####

In your coverage, please use this URL to provide access to the freely available paper in PLOS Biology: http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3002089

Citation: Galanti M, Patiño-Galindo JA, Filip I, Morita H, Galianese A, Youssef M, et al. (2023) Virome Data Explorer: A web resource to longitudinally explore respiratory viral infections, their interactions with other pathogens and host transcriptomic changes in over 100 people. PLoS Biol 21(12): e3002089. https://doi.org/10.1371/journal.pbio.3002089

Author Countries: United States

Funding: This work was supported by the Defense Advanced Research Projects Agency contract W911NF-16-2-0035 (PI- JS) and R01GM117591 (PI – RR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.



Journal

PLoS Biology

DOI

10.1371/journal.pbio.3002089

Method of Research

Observational study

Subject of Research

People

COI Statement

Competing interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: RR is a member of the SAB of Diatech Pharmacogenetics and Flahy and founder of Genotwin. JS and Columbia University disclose partial ownership of SK Analytics. JS discloses consulting for BNI. DSR is now employee of “Merck & Co., Inc., Kenilworth, NJ, USA” and may hold stock. IF is now employee of Abbvie and OE is currently employee of Genotwin. All other authors have no competing interests.

Share12Tweet8Share2ShareShareShare2

Related Posts

Exploring Motor Differences in Neurodivergence: Initial Insights

October 19, 2025

Innovative Surgical Transfer Sheet: A Randomized Trial

October 19, 2025

Exploring Inflammatory Pathways in Hypertensive Nephrosclerosis Progression

October 19, 2025

AT1R Autoantibody Disrupts Fetal Liver Glycogen Synthesis

October 19, 2025

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1264 shares
    Share 505 Tweet 316
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    296 shares
    Share 118 Tweet 74
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    126 shares
    Share 50 Tweet 32
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    103 shares
    Share 41 Tweet 26

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Unveiling Sex-Switching in Silver Pomfret Juveniles

Exploring Motor Differences in Neurodivergence: Initial Insights

Innovative Surgical Transfer Sheet: A Randomized Trial

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 65 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.